)
CSL Behring is committed to supporting progress in the area of coagulation in the long run. Based on recent publications and feedback from the medical community, allowing the next generation of coagulation specialists to medically and scientifically establish themselves, it is important to ensure continued progress in this therapeutic area. CSL Behring will fund the ninth cycle of a global grant program to support the above objective.
Grant Details and Eligibility
CSL Behring will set five global start-up grants of €20,000 each.
The grants are reserved for researchers who hold a medical degree. Applicants with less than five years of faculty experience in hemostasis will be preferred.
No matching funding is a prerequisite for this grant. The grants will be available for clinical and/or preclinical research in the area of coagulation.
